NLRP3 and mantle cell lymphoma: Importantly, pharmacological blockade of Nlrp3 reduced inflammation caused by cytotoxic CD8+ T cells in this mouse model of MCL, thus identifying this inflammasome, as well as CD8+ T cell-mediated cytotoxicity, as potential targets for immunotherapy.